Literature DB >> 20649762

Long-term natural history of acquired cystic disease of the kidney.

Isao Ishikawa1, Satoshi Hayama, Kyoko Morita, Tetsuya Nakazawa, Hitoshi Yokoyama, Ryumon Honda, Kyoko Satoh, Tatsuyuki Kakuma.   

Abstract

Patients with acquired cystic disease of the kidney (ACDK) were followed longitudinally over an average of 21.7 +/- 5.4 years to determine the natural history of the disease; that is, how big the kidneys become, when the kidney size reaches a plateau, and when the size regresses. Twenty-seven male and 20 female patients with chronic glomerulonephritis treated at our hospital were investigated. CT scans were performed once a year and kidney volume was measured. Two different quadratic curves with a node of 5.2 years for males and 2.5 years for females after the start of hemodialysis were fitted to log-transformed kidney volume to the duration of hemodialysis using a linear mixed model. The maximum kidney volume in male patients was obtained 21.1 years after the start of hemodialysis using this model. Peak values of kidney volume were demonstrated in 19 of 26 cases during the observation period. The median peak value (interquartile range) of bilateral kidney volumes was 274 (165-849) mL/1.73 m(2) occurring 19.1 +/- 4.5 years after the start of dialysis. In one male patient who had undergone nephrectomy due to renal cell carcinoma and in two of the remaining 26 male patients, the maximum kidney volume of 782 (residual kidney), 1151, and 1129 mL regressed to 428, 616, and 847 mL (reduction rate: 45.3, 46.5, and 25.0%) at 20.6, 25.4, and 23.1 years after the start of hemodialysis, respectively. Kidney enlargement due to ACDK reached a plateau after 21.1 years of hemodialysis in the male patients. Partial regression of severe ACDK may occur naturally after long-term hemodialysis without renal transplantation.

Entities:  

Mesh:

Year:  2010        PMID: 20649762     DOI: 10.1111/j.1744-9987.2010.00819.x

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN: 1744-9979            Impact factor:   1.762


  5 in total

1.  Renal cell carcinoma in kidney transplant recipients and dialysis patients.

Authors:  Hyung Ho Lee; Kyung Hwa Choi; Seung Choul Yang; Woong Kyu Han
Journal:  Korean J Urol       Date:  2012-04-18

2.  Clinical and pathological outcomes of renal cell carcinoma (RCC) in native kidneys of patients with end-stage renal disease: a long-term comparative retrospective study with RCC diagnosed in the general population.

Authors:  Alberto Breda; Giuseppe Lucarelli; Giuseppe Luccarelli; Oscar Rodriguez-Faba; Luis Guirado; Carmen Facundo; Carlo Bettocchi; Loreto Gesualdo; Giuseppe Castellano; Giuseppe Grandaliano; Michele Battaglia; Juan Palou; Pasquale Ditonno; Humberto Villavicencio
Journal:  World J Urol       Date:  2014-02-07       Impact factor: 4.226

Review 3.  Why kidneys fail in autosomal dominant polycystic kidney disease.

Authors:  Jared J Grantham; Sumanth Mulamalla; Katherine I Swenson-Fields
Journal:  Nat Rev Nephrol       Date:  2011-08-23       Impact factor: 28.314

4.  Simultaneous nephrectomy during kidney transplantation for polycystic kidney disease does not detrimentally impact comorbidity and graft survival.

Authors:  Tom Darius; Sébastien Bertoni; Martine De Meyer; Antoine Buemi; Arnaud Devresse; Nada Kanaan; Eric Goffin; Michel Mourad
Journal:  World J Transplant       Date:  2022-05-18

5.  Polycystic kidney disease and cancer after renal transplantation.

Authors:  James B Wetmore; James P Calvet; Alan S L Yu; Charles F Lynch; Connie J Wang; Bertram L Kasiske; Eric A Engels
Journal:  J Am Soc Nephrol       Date:  2014-05-22       Impact factor: 14.978

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.